The Next Generation of Antibody Therapeutics?: Synthetic Polyclonal Antibodies from Symphogen

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.4, Iss.11, 2006-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 759-772

Bentham Science Publishers

Access to resources Recommend Favorite

The Endocannabinoid Signaling System: A Potential Target for Next- Generation Therapeutics for Alcoholism

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-08 ,pp. : 769-779

Bentham Science Publishers

Access to resources Recommend Favorite

In Silico-In Vitro Screening of Protein-Protein Interactions: Towards the Next Generation of Therapeutics

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 2, 2008-04 ,pp. : 103-122

Bentham Science Publishers

Access to resources Recommend Favorite

Current and Next Generation Topical Anti-Skin Cancer Therapeutics

Drug Delivery Letters, Vol. 6, Iss. 1, 2016-10 ,pp. : 46-56

Bentham Science Publishers

Access to resources Recommend Favorite

A Unique Industrial – Academic Collaboration Towards the Next Generation of Schizophrenia Therapeutics

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 3, 2014-02 ,pp. : 304-312

Bentham Science Publishers

Access to resources Recommend Favorite